Targeting the epigenome for the treatment and prevention of lung cancer

David S. Schrump, Dao Nguyen

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Alterations in chromatin structure resulting from aberrant DNA methylation and perturbations of the histone code profoundly influence gene expression during pulmonary carcinogenesis. Recent studies indicate that DNA demethylating agents and histone deacetylase (HDAC) inhibitors synergistically induce gene expression and apoptosis in cultured lung cancer cells, and prevent lung cancer development in animals following exposure to tobacco carcinogens. Preliminary clinical trials have established proof of principle regarding the use of DNA demethylating agents and HDAC inhibitors for enhancing immunogenicity and apoptosis of lung cancer cells, and have revealed the complexities concerning the mechanisms by which chromatin remodeling agents mediate antitumor effects in vivo. These data support additional investigations pertaining to the epigenetics of lung cancer, and the evaluation of chromatin remodeling agents for the treatment and prevention of this disease.

Original languageEnglish
Pages (from-to)488-502
Number of pages15
JournalSeminars in Oncology
Volume32
Issue number5
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Lung Neoplasms
Histone Deacetylase Inhibitors
Chromatin Assembly and Disassembly
Histone Code
Apoptosis
Gene Expression
DNA
DNA Methylation
Epigenomics
Carcinogens
Antineoplastic Agents
Chromatin
Tobacco
Carcinogenesis
Clinical Trials
Lung

ASJC Scopus subject areas

  • Oncology

Cite this

Targeting the epigenome for the treatment and prevention of lung cancer. / Schrump, David S.; Nguyen, Dao.

In: Seminars in Oncology, Vol. 32, No. 5, 01.10.2005, p. 488-502.

Research output: Contribution to journalArticle

@article{8466ecf3b6bd4e9b9f3db3fe3a2c38d7,
title = "Targeting the epigenome for the treatment and prevention of lung cancer",
abstract = "Alterations in chromatin structure resulting from aberrant DNA methylation and perturbations of the histone code profoundly influence gene expression during pulmonary carcinogenesis. Recent studies indicate that DNA demethylating agents and histone deacetylase (HDAC) inhibitors synergistically induce gene expression and apoptosis in cultured lung cancer cells, and prevent lung cancer development in animals following exposure to tobacco carcinogens. Preliminary clinical trials have established proof of principle regarding the use of DNA demethylating agents and HDAC inhibitors for enhancing immunogenicity and apoptosis of lung cancer cells, and have revealed the complexities concerning the mechanisms by which chromatin remodeling agents mediate antitumor effects in vivo. These data support additional investigations pertaining to the epigenetics of lung cancer, and the evaluation of chromatin remodeling agents for the treatment and prevention of this disease.",
author = "Schrump, {David S.} and Dao Nguyen",
year = "2005",
month = "10",
day = "1",
doi = "10.1053/j.seminoncol.2005.07.007",
language = "English",
volume = "32",
pages = "488--502",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Targeting the epigenome for the treatment and prevention of lung cancer

AU - Schrump, David S.

AU - Nguyen, Dao

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Alterations in chromatin structure resulting from aberrant DNA methylation and perturbations of the histone code profoundly influence gene expression during pulmonary carcinogenesis. Recent studies indicate that DNA demethylating agents and histone deacetylase (HDAC) inhibitors synergistically induce gene expression and apoptosis in cultured lung cancer cells, and prevent lung cancer development in animals following exposure to tobacco carcinogens. Preliminary clinical trials have established proof of principle regarding the use of DNA demethylating agents and HDAC inhibitors for enhancing immunogenicity and apoptosis of lung cancer cells, and have revealed the complexities concerning the mechanisms by which chromatin remodeling agents mediate antitumor effects in vivo. These data support additional investigations pertaining to the epigenetics of lung cancer, and the evaluation of chromatin remodeling agents for the treatment and prevention of this disease.

AB - Alterations in chromatin structure resulting from aberrant DNA methylation and perturbations of the histone code profoundly influence gene expression during pulmonary carcinogenesis. Recent studies indicate that DNA demethylating agents and histone deacetylase (HDAC) inhibitors synergistically induce gene expression and apoptosis in cultured lung cancer cells, and prevent lung cancer development in animals following exposure to tobacco carcinogens. Preliminary clinical trials have established proof of principle regarding the use of DNA demethylating agents and HDAC inhibitors for enhancing immunogenicity and apoptosis of lung cancer cells, and have revealed the complexities concerning the mechanisms by which chromatin remodeling agents mediate antitumor effects in vivo. These data support additional investigations pertaining to the epigenetics of lung cancer, and the evaluation of chromatin remodeling agents for the treatment and prevention of this disease.

UR - http://www.scopus.com/inward/record.url?scp=24744456138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744456138&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2005.07.007

DO - 10.1053/j.seminoncol.2005.07.007

M3 - Article

VL - 32

SP - 488

EP - 502

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 5

ER -